Low-dose hydrocortisone replacement is associated with improved arterial stiffness index and blood pressure dynamics in severely adrenocorticotrophin-deficient hypopituitary male patients
The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
Abstract
Objective Increased cardiovascular and cerebrovascular morbidity and mortality in hypopituitary subjects may be linked to inappropriate glucocorticoid exposure; however, the pathophysiology remains unclear. We aimed to examine the effect of three commonly prescribed hydrocortisone (HC) regimens on vascular risk factors. Design An open crossover study randomising ten hypopituitary men with severe adrenocorticotrophic hormone deficiency to three HC dose regimens: dose A (20mg mane and 10mg tarde), dose B (10mg mane and 10mg tarde) and dose C (10mg mane and 5mg tarde). Methods Following 6 weeks on each regimen, participants underwent 24-h serum cortisol sampling, 24-h ambulatory blood pressure (BP) measurements, calculation of the Ambulatory Arterial Stiffness Index (AASI), oral glucose tolerance testing and fasting serum osteoprotegerin (OPG) sampling. Results There were no differences in 24-h BP between dose regimens and controls; however, low-dose HC replacement (dose C) was associated with the lowest AASI, indicating a less stiff arterial tree (P Conclusion Currently prescribed HC replacement doses do not result in significant differences in absolute BP levels or improvements in insulin sensitivity. However, lower HC doses may result in lower arterial stiffness and a more physiological nocturnal BP dip. Long-term studies are required to confirm these findings and evaluate their impact on vascular morbidity in this patient group.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Whereas, a small prospective study of patients with hypopituitarism taking 30 mg HC did not report improvements in weight, 24-hour urine-free cortisol, glucose, or HbA1C (210).”
From Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline (2016) · cites this paper as [210]
Citations
Cites
Matthews, D. R., Hosker, J. P., Rudenski, A. S., Naylor, B. A., Treacher, D. F., & Turner, R. C. (1985) · Diabetologia · doi:10.1007/bf00280883 · Cited by 31,502
Premature mortality due to cardiovascular disease in hypopituitarism
Rosén, T., & Bengtsson, B.-Å. (1990) · The Lancet · doi:10.1016/0140-6736(90)91812-o · Cited by 1,402
Sutton-Tyrrell, K., Najjar, S. S., Boudreau, R. M., Venkitachalam, L., Kupelian, V., Simonsick, E. M., Havlik, R., Lakatta, E. G., Spurgeon, H., Kritchevsky, S., et al. (2005) · Circulation · doi:10.1161/circulationaha.104.483628 · Cited by 1,249
Dolan, E., Stanton, A., Thijs, L., Hinedi, K., Atkins, N., McClory, S., Hond, E. D., McCormack, P., Staessen, J. A., & O’Brien, E. (2005) · Hypertension · doi:10.1161/01.hyp.0000170138.56903.7a · Cited by 1,227
Self-citationAssociation between premature mortality and hypopituitarism
Tomlinson, J., Holden, N., Hills, R., Wheatley, K., Clayton, R., Bates, A., Sheppard, M., & Stewart, P. (2001) · The Lancet · doi:10.1016/s0140-6736(00)04006-x · Cited by 1,006
A Model-Based Method for Assessing Insulin Sensitivity From the Oral Glucose Tolerance Test
Mari, A., Pacini, G., Murphy, E., Ludvik, B., & Nolan, J. J. (2001) · Diabetes Care · doi:10.2337/diacare.24.3.539 · Cited by 806
Insulin Sensitivity and Atherosclerosis
Howard, G., O’Leary, D. H., Zaccaro, D., Haffner, S., Rewers, M., Hamman, R., Selby, J. V., Saad, M. F., Savage, P., & Bergman, R. (1996) · Circulation · doi:10.1161/01.cir.93.10.1809 · Cited by 729
Increased cerebrovascular mortality in patients with hypopituitarism
Bülow, B., Hagmar, L., Mikoczy, Z., Nordström, C., & Erfurth, E. M. (1997) · Clinical Endocrinology · doi:10.1046/j.1365-2265.1997.d01-1749.x · Cited by 542
The effect of hypopituitarism on life expectancy.
Bates, A. S., Van't Hoff, W., Jones, P. J., & Clayton, R. N. (1996) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.81.3.8772595 · Cited by 475
Amato, G. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.77.6.1671 · Cited by 440
Dolan, E., Thijs, L., Li, Y., Atkins, N., McCormack, P., McClory, S., O’Brien, E., Staessen, J. A., & Stanton, A. V. (2006) · Hypertension · doi:10.1161/01.hyp.0000200699.74641.c5 · Cited by 394
Self-citationMortality in Patients with Pituitary Disease
Sherlock, M., Ayuk, J., Tomlinson, J. W., Toogood, A. A., Aragon-Alonso, A., Sheppard, M. C., Bates, A. S., & Stewart, P. M. (2010) · Endocrine Reviews · doi:10.1210/er.2009-0033 · Cited by 392
Markussis, V., Beshyah, S. A., Johnston, D. G., Fisher, C., Nicolaides, A. N., & Sharp, P. (1992) · The Lancet · doi:10.1016/0140-6736(92)92892-j · Cited by 390
Ambulatory Arterial Stiffness Index Derived From 24-Hour Ambulatory Blood Pressure Monitoring
Li, Y., Wang, J.-G., Dolan, E., Gao, P.-J., Guo, H.-F., Nawrot, T., Stanton, A. V., Zhu, D.-L., O’Brien, E., & Staessen, J. A. (2006) · Hypertension · doi:10.1161/01.hyp.0000200695.34024.4c · Cited by 371
Self-citationCardiovascular risk factors in adult patients with growth hormone deficiency
Rosén, T., Edén, S., Larson, G., Wilhelmsen, L., & Bengtsson, B.-Å. (1993) · Acta Endocrinologica · doi:10.1530/acta.0.1290195 · Cited by 338
Johannsson, G., Nilsson, A. G., Bergthorsdottir, R., Burman, P., Dahlqvist, P., Ekman, B., Engström, B. E., Olsson, T., Ragnarsson, O., Ryberg, M., et al. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-1926 · Cited by 329
Filipsson, H., Monson, J. P., Koltowska-Häggström, M., Mattsson, A., & Johannsson, G. (2006) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2006-0524 · Cited by 321
Growth hormone-deficient adults are insulin-resistant
Johansson, J.-O., Fowelin, J., Landin, K., Lager, I., & Bengtsson, B.-Å. (1995) · Metabolism · doi:10.1016/0026-0495(95)90004-7 · Cited by 275
Growth Hormone (GH) Treatment Reverses Early Atherosclerotic Changes in GH-Deficient Adults1
Pfeifer, M., Verhovec, R., Zizek, B., Prezelj, J., Poredos, P., & Clayton, R. N. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.2.5456 · Cited by 260
Szulc, P., & Delmas, P. D. (2008) · Osteoporosis International · doi:10.1007/s00198-008-0660-9 · Cited by 220
Sherlock, M., Reulen, R. C., Alonso, A. A., Ayuk, J., Clayton, R. N., Sheppard, M. C., Hawkins, M. M., Bates, A. S., & Stewart, P. M. (2009) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-1097 · Cited by 185
Ambulatory arterial stiffness index predicts stroke in a general population
Hansen, T. W., Staessen, J. A., Torp-Pedersen, C. T., Rasmussen, S. L., Li, Y., Dolan, E., Thijs, L., Wang, J., O'Brien, E. T., Ibsen, H., et al. (2006) · Journal of Hypertension · doi:10.1097/01.hjh.0000249703.57478.78 · Cited by 163
Growth Hormone (GH) Treatment Reverses Early Atherosclerotic Changes in GH-Deficient Adults
Pfeifer, M. (1999) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.2.453 · Cited by 160
Assays for Insulin, Proinsulin(S) and C-Peptide
Clark, P. M. (1999) · Annals of Clinical Biochemistry: International Journal of Laboratory Medicine · doi:10.1177/000456329903600501 · Cited by 158
Kikuya, M., Staessen, J. A., Ohkubo, T., Thijs, L., Metoki, H., Asayama, K., Obara, T., Inoue, R., Li, Y., Dolan, E., et al. (2007) · Stroke · doi:10.1161/01.str.0000259604.67283.69 · Cited by 149
Bülow, B., Hagmar, L., Eskilsson, J., & Erfurth, E. M. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.2.6346 · Cited by 142
Clinical value of ambulatory blood pressure monitoring
Mallion, J.-M., Baguet, J.-P., Siché, J.-P., Tremel, F., & Gaudemaris, R. D. (1999) · Journal of Hypertension · doi:10.1097/00004872-199917050-00001 · Cited by 108
Nybo, M., & Rasmussen, L. M. (2008) · European Journal of Endocrinology · doi:10.1530/eje-08-0554 · Cited by 98
Bulow, B. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.85.2.574 · Cited by 92
Exogenous glucocorticoid eliminates or reverses circadian blood pressure variations
Imai, Y., Abe, K., Sasaki, S., Minami, N., Munakata, M., Nihei, M., Sekino, H., & Yoshinaga, K. (1989) · Journal of Hypertension · doi:10.1097/00004872-198902000-00006 · Cited by 91
Glucocorticoid replacement and mortality in patients with nonfunctioning pituitary adenoma
Zueger, T., Kirchner, P., Herren, C., Fischli, S., Zwahlen, M., Christ, E., & Stettler, C. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2012-2432 · Cited by 90
Elhadd, T. A. (2001) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.86.9.4223 · Cited by 88
Lekakis, J. P., Zakopoulos, N. A., Protogerou, A. D., Papaioannou, T., Kotsis, V., Pitiriga, V. C., Tsitsirikos, M. D., Stamatelopoulos, K., Papamichael, C. M., & Mavrikakis, M. (2004) · International Journal of Cardiology · doi:10.1016/j.ijcard.2004.04.014 · Cited by 80
Growth hormone deficiency and vascular risk
McCallum, R. W., Petrie, J. R., Dominiczak, A. F., & Connell, J. M. C. (2002) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2002.01559.x · Cited by 79
Danilowicz, K., Bruno, O. D., Manavela, M., Gomez, R. M., & Barkan, A. (2008) · Pituitary · doi:10.1007/s11102-008-0126-2 · Cited by 72
Cardiovascular function and glucocorticoid replacement in patients with hypopituitarism
Dunne, F. P., Elliot, P., Gammage, M. D., Stallard, T., Ryan, T., Sheppard, M. C., & Stewart, P. M. (1995) · Clinical Endocrinology · doi:10.1111/j.1365-2265.1995.tb02928.x · Cited by 70
Corticosteroid‐binding globulin regulates cortisol pharmacokinetics
Perogamvros, I., Aarons, L., Miller, A. G., Trainer, P. J., & Ray, D. W. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2010.03897.x · Cited by 59
Excess mortality in women with pituitary disease: a meta‐analysis
Nielsen, E. H., Lindholm, J., & Laurberg, P. (2007) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2007.02947.x · Cited by 58
Petersons, C. J., Mangelsdorf, B. L., Thompson, C. H., & Burt, M. G. (2014) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2013-4305 · Cited by 54
Self-citationSuliman, A. M., Freaney, R., Smith, T. P., McBrinn, Y., Murray, B., & McKenna, T. J. (2003) · Clinical Endocrinology · doi:10.1046/j.1365-2265.2003.01860.x · Cited by 50
Ambulatory arterial stiffness index: determinants and outcome
Li, Y., Dolan, E., Wang, J., Thijs, L., Zhu, D., Staessen, J. A., O'Brien, E. T., & Stanton, A. V. (2006) · Blood Pressure Monitoring · doi:10.1097/01.mbp.0000189791.90488.a1 · Cited by 45
Self-citationAortic Stiffness is an Independent Predictor of Stroke in Hypertensive Patients
Pereira, T. S., Maldonado, J. M. P., Pereira, L., & Conde, J. (2013) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20130079 · Cited by 42
Osteoprotegerin as a marker of atherosclerosis: A systematic update
Hosbond, S. E., Poulsen, T. S., Diederichsen, A. C. P., Nybo, M., Rasmussen, L. M., & Mickley, H. (2012) · Scandinavian Cardiovascular Journal · doi:10.3109/14017431.2012.685491 · Cited by 38
Circadian Blood Pressure Profile in Patients with Active Cushing's Disease and after Long-term Cure
Giraldi, F. P., Toja, P. M., Martin, M., Maronati, A., Scacchi, M., Omboni, S., Cavagnini, F., & Parati, G. (2007) · Hormone and Metabolic Research · doi:10.1055/s-2007-992813 · Cited by 37
He, F. J., Marrero, N. M., & MacGregor, G. A. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.112979 · Cited by 36
Behan, L., Rogers, B., Hannon, M. J., O’Kelly, P., Tormey, W., Smith, D., Thompson, C. J., & Agha, A. (2011) · Clinical Endocrinology · doi:10.1111/j.1365-2265.2011.04074.x · Cited by 27
Self-citationBehan, L.-A., Kelleher, G., Hannon, M. J., Brady, J. J., Rogers, B., Tormey, W., Smith, D., Thompson, C. J., McKenna, M. J., & Agha, A. (2014) · European Journal of Endocrinology · doi:10.1530/eje-13-0596 · Cited by 23
Self-citation
Cited by
Hormonal Replacement in Hypopituitarism in Adults: An Endocrine Society Clinical Practice Guideline
Fleseriu, M., Hashim, I. A., Karavitaki, N., Melmed, S., Murad, M. H., Salvatori, R., & Samuels, M. H. (2016) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2118 · Cited by 945
Hahner, S., Ross, R. J., Arlt, W., Bancos, I., Burger-Stritt, S., Torpy, D. J., Husebye, E. S., & Quinkler, M. (2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00252-7 · Cited by 223
Novel insights into glucocorticoid replacement therapy for pediatric and adult adrenal insufficiency
Oprea, A., Bonnet, N., Pollé, O. G., & Lysy, P. A. (2019) · Therapeutic Advances in Endocrinology and Metabolism · doi:10.1177/2042018818821294 · Cited by 69
Smith, D. J. F., Prabhudev, H., Choudhury, S., & Meeran, K. M. (2017) · Endocrine Connections · doi:10.1530/ec-17-0257 · Cited by 49
Self-citationIncreased Cardiovascular Risk in Patients with Adrenal Insufficiency: A Short Review
Rahvar, A., Haas, C. S., Danneberg, S., & Harbeck, B. (2017) · BioMed Research International · doi:10.1155/2017/3691913 · Cited by 42
Metadata
- Authors
- Behan, L.-A., Carmody, D., Rogers, B., Hannon, M. J., Davenport, C., Tormey, W., Smith, D., Thompson, C. J., Stanton, A., & Agha, A.
- Affiliations
- Royal College of Surgeons in Ireland (IE)
- University of Ulster (GB)
- Corresponding author
- Agha, Amar
- ORCID
- Venue
- European Journal of Endocrinology
- Publisher
- Oxford University Press (OUP)
- Published
- 2016-06
- Volume
- 174
- Issue
- 6
- Pages
- 791-799
- ISSN
- 0804-4643 (ISSN-L)
- 1479-683X
- OpenAlex
- W2323572784
- Semantic Scholar
- dd4499aeb6963f9885abe11f1f610bc3e8ef96ff
- Cited by
- 28
- References
- 45
- Citations by year
- 2025: 5 · 2024: 2 · 2023: 1 · 2022: 2 · 2021: 4 · 2020: 3 · 2019: 6 · 2018: 1 · 2017: 3 · 2016: 1
- FWCI
- 3.68
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- European Journal of Endocrinology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal Regulation and Hypertension
- Keywords
- hydrocortisone replacement, hypopituitarism, arterial stiffness, ambulatory arterial stiffness index, blood pressure dynamics, nocturnal blood pressure dipping, osteoprotegerin, glucose tolerance, glucocorticoid dose, cardiovascular risk
- MeSH terms
- Adrenocorticotropic Hormone, Adult, Blood Pressure, Double-Blind Method, Humans, Hydrocortisone, Hypopituitarism, Male, Middle Aged, Treatment Outcome, Cross-Over Studies, Blood Pressure Monitoring, Ambulatory, Hormone Replacement Therapy, Vascular Stiffness
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.